269 related articles for article (PubMed ID: 9357537)
21. Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
Gangjee A; Lin X; Queener SF
J Med Chem; 2004 Jul; 47(14):3689-92. PubMed ID: 15214795
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological activities of tricyclic conformationally restricted tetrahydropyrido annulated furo[2,3-d]pyrimidines as inhibitors of dihydrofolate reductases.
Gangjee A; Elzein E; Queener SF; McGuire JJ
J Med Chem; 1998 Apr; 41(9):1409-16. PubMed ID: 9554874
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of dihydrofolate reductases from Toxoplasma gondii, Pneumocystis carinii, and rat liver by rotationally restricted analogues of pyrimethamine and metoprine.
Rosowsky A; Queener SF; Cody V
Drug Des Discov; 1999 Jul; 16(1):25-40. PubMed ID: 10466054
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
Gangjee A; Lin X; Kisliuk RL; McGuire JJ
J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.
Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL
J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Rosowsky A; Hynes JB; Queener SF
Antimicrob Agents Chemother; 1995 Jan; 39(1):79-86. PubMed ID: 7695334
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activities of conformationally restricted, tricyclic nonclassical antifolates as inhibitors of dihydrofolate reductases.
Gangjee A; Shi J; Queener SF
J Med Chem; 1997 Jun; 40(12):1930-6. PubMed ID: 9191971
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of nonclassical 2,4-diamino-5-methylpyrido[2,3-d]pyrimidines with novel side chain substituents as potential inhibitors of dihydrofolate reductases.
Gangjee A; Vasudevan A; Queener SF
J Med Chem; 1997 Feb; 40(4):479-85. PubMed ID: 9046338
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 2,4-diamino-6-[2'-O-(omega-carboxyalkyl)oxydibenz[b,f]azepin-5-yl]methylpteridines as potent and selective inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase.
Rosowsky A; Fu H; Chan DC; Queener SF
J Med Chem; 2004 May; 47(10):2475-85. PubMed ID: 15115391
[TBL] [Abstract][Full Text] [Related]
31. Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
Cody V; Galitsky N; Luft JR; Pangborn W; Queener SF; Gangjee A
Acta Crystallogr D Biol Crystallogr; 2002 Sep; 58(Pt 9):1393-9. PubMed ID: 12198294
[TBL] [Abstract][Full Text] [Related]
32. 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.
Gangjee A; Jain HD; Phan J; Guo X; Queener SF; Kisliuk RL
Bioorg Med Chem; 2010 Jan; 18(2):953-61. PubMed ID: 20056546
[TBL] [Abstract][Full Text] [Related]
33. 6-substituted 2,4-diamino-5-methylpyrido[2,3-d]pyrimidines as inhibitors of dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
J Med Chem; 1995 May; 38(10):1778-85. PubMed ID: 7752201
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and DHFR inhibitory activity of a series of 6-substituted-2,4-diaminothieno[2,3-d]pyrimidines.
Donkor IO; Li H; Queener SF
Eur J Med Chem; 2003 Jun; 38(6):605-11. PubMed ID: 12832132
[TBL] [Abstract][Full Text] [Related]
35. Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium.
Forsch RA; Queener SF; Rosowsky A
Bioorg Med Chem Lett; 2004 Apr; 14(7):1811-5. PubMed ID: 15026078
[TBL] [Abstract][Full Text] [Related]
36. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
37. CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductase.
Gangjee A; Lin X
J Med Chem; 2005 Mar; 48(5):1448-69. PubMed ID: 15743188
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
Gangjee A; Adair O; Queener SF
Bioorg Med Chem; 2001 Nov; 9(11):2929-35. PubMed ID: 11597474
[TBL] [Abstract][Full Text] [Related]
39. 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
Rosowsky A; Mota CE; Queener SF; Waltham M; Ercikan-Abali E; Bertino JR
J Med Chem; 1995 Mar; 38(5):745-52. PubMed ID: 7877140
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, antifolate, and antitumor activities of classical and nonclassical 2-amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines.
Gangjee A; Vidwans A; Elzein E; McGuire JJ; Queener SF; Kisliuk RL
J Med Chem; 2001 Jun; 44(12):1993-2003. PubMed ID: 11384244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
